Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era

被引：0
|
作者：
Sei Naito
Tomoyuki Kato
Kazuyuki Numakura
Shingo Hatakeyama
Tomoyuki Koguchi
Shuya Kandori
Yoshihide Kawasaki
Hisanobu Adachi
Renpei Kato
Shintaro Narita
Hayato Yamamoto
Soichiro Ogawa
Sadafumi Kawamura
Wataru Obara
Akihiro Ito
Hiroyuki Nishiyama
Yoshiyuki Kojima
Chikara Ohyama
Tomonori Habuchi
Norihiko Tsuchiya
机构：
[1] Yamagata University Faculty of Medicine,Department of Urology
[2] Akita University Graduate School of Medicine,Department of Urology
[3] Hirosaki University Graduate School of Medicine,Department of Urology
[4] Fukushima Medical University School of Medicine,Department of Urology
[5] University of Tsukuba Graduate School of Medicine,Department of Urology
[6] Tohoku University School of Medicine,Department of Urology
[7] Miyagi Cancer Center,Department of Urology
[8] Iwate Medical University School of Medicine,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic renal cell carcinoma; Overall survival; Prognosis; Prognostic model; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1947 / 1954
页数：7
相关论文
共 50 条
  • [21] Treatment of metastatic renal cell carcinoma: immunotherapy in the era of molecular targeted therapy
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A6 - A7
  • [22] Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy
    Kawano, Yoshiaki
    Takahashi, Wataru
    Eto, Masatoshi
    Kamba, Tomomi
    Miyake, Hideaki
    Fujisawa, Masato
    Kamai, Takao
    Uemura, Hirotsugu
    Tsukamoto, Taiji
    Azuma, Haruhito
    Matsubara, Akio
    Nishimura, Kazuo
    Nakamura, Tsuyoshi
    Ogawa, Osamu
    Naito, Seiji
    CANCER SCIENCE, 2016, 107 (07) : 1013 - 1017
  • [23] Targeted therapy for metastatic renal cell carcinoma
    Motzer, Robert J.
    Bukowski, Ronald M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5601 - 5608
  • [24] Targeted therapy for metastatic renal cell carcinoma
    Hofmann, Fabian
    Hwang, Eu Chang
    Lam, Thomas B. L.
    Bex, Axel
    Yuan, Yuhong
    Marconi, Lorenzo S. O.
    Ljungberg, Borje
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (10):
  • [25] Targeted Therapy for Metastatic Renal Cell Carcinoma
    Afriansyah, Andika
    Hamid, Agus Rizal A. H.
    Mochtar, Chaidir A.
    Umbas, Rainy
    ACTA MEDICA INDONESIANA, 2016, 48 (04) : 335 - 347
  • [26] Targeted therapy in metastatic renal cell carcinoma
    De Mulder, P. H. M.
    ANNALS OF ONCOLOGY, 2007, 18 : 98 - 102
  • [27] Targeted therapy for metastatic renal cell carcinoma
    Patel, PH
    Chaganti, RSK
    Motzer, RJ
    BRITISH JOURNAL OF CANCER, 2006, 94 (05) : 614 - 619
  • [28] Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era
    Tatsugami, Katsunori
    Shinohara, Nobuo
    Kondo, Tsunenori
    Yamasaki, Toshinari
    Eto, Masatoshi
    Tsushima, Tomoyasu
    Terachi, Toshiro
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (08) : 736 - 740
  • [29] Targeted therapy for metastatic renal cell carcinoma
    P H Patel
    R S K Chaganti
    R J Motzer
    British Journal of Cancer, 2006, 94 : 614 - 619
  • [30] Survival of Patients Undergoing Cytoreductive Surgery for Metastatic Renal Cell Carcinoma in the Targeted-Therapy Era
    Abern, Michael R.
    Scosyrev, Emelian
    Tsivian, Matvey
    Messing, Edward M.
    Polascik, Thomas J.
    Dudek, Arkadiusz Z.
    ANTICANCER RESEARCH, 2014, 34 (05) : 2405 - 2411
12345